Category Archives: US – Malaysia FTA

Petition to the Malaysian Minister of Health: Make Sofosbuvir available, fix patent laws!

Hepatitis C patients in Malaysia urgently need access to affordable Sofosbuvir. Help them by signing this petition to the Health Minister of Malaysia in the run-up to the International Harm Reduction Conference in Kuala Lumpur.

Posted in Compulsory Licensing, Evergreening, Hepatitis C, IPR policy, Patent Term Extension, Petitions, Post-grant opposition, Pre-grant opposition, Sofosbuvir, US - Malaysia FTA | Leave a comment

FTA signals death knell for AIDS patients

Source: Free Malaysia Today K Pragalath| December 8, 2011 Malaysia’s free trade agreement with the US will deprive them of affordable generic drugs. PETALING JAYA: When Malaysia signs its free trade agreement (FTA) with the United States next July, it will … Continue reading

Posted in HIV/Aids, Pricing, US - Malaysia FTA | Leave a comment